(Allergan plc)

	AGN latest price $160.9100 (0.26%) ($160.2100 - $162.1700) on Thu. Aug. 1, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	3.65% (three month average)
RSI	25
Latest Price	$160.9100(0.26%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN declines -1% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IVW(82%)    IWF(82%)    VT(82%)    VUG(82%)    XLC(82%)
Factors Impacting AGN price	AGN will decline at least -1.825% in a week (0% probabilities).   VXX(-70%)    VIXM(-61%)    TLT(-42%)    IFRA(-40%)    BWX(-13%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.825% (StdDev 3.65%)
Hourly BBV	0 ()
Intraday Trend	0.3%

1 - 5 Day Possible Target	$159.37(-0.96%)
Resistance Level	$163.13
5 Day Moving Average	$160.85(0.04%)
10 Day Moving Average	$161.25(-0.21%)
20 Day Moving Average	$163.13(-1.36%)
To recent high	-5.2%
To recent low	39%
Market Cap	$53.052b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed